短期课程*

Short courses at Drug Discovery Chemistry are designed to be instructional and interactive. The class size allows for one-on-one interactions between the instructors and attendees. Time is also built into the schedule for Q&A throughout. The courses include introductions for those new to the field as well as explanations on more technical aspects than time allows during our main conference presentations. Instructors are drawn from industry and academics alike, many of whom are recognized authorities in their fields or have teaching experience. Below is a list of the courses that were offered in 2018; most will be repeated and a few new topics will be added for 2019 – check back in mid-October 2018 for a more complete listing and schedule for 2019’s Drug Discovery Chemistry.

Monday April 8, 10:00 am – 1:00 pm

Covalent Fragments: Applications in Target-Based and Phenotypic Screens

Instructor:
Alexander Statsyuk, PhD, Assistant Professor, Department of Pharmacological and Pharmaceutical Sciences, University of Houston

Trends in Physical Properties of Drugs

Instructor:
Terry Stouch, PhD, President, R&D, Science for Solutions, LLC

Introduction to GPCR-Based Drug Discovery

Instructor:
Annette Gilchrist, PhD, Professor, Department of Pharmacology, Midwestern University

Monday April 8, 2:00 – 5:00 pm

Ligand-Receptor Molecular Interactions and Drug Design

Instructor:
Maricel Torrent, PhD, Senior Scientist, AbbVie

Methodologies for Optimizing Drug Clearance and Drug-Drug Interactions

Instructors:
Zhengyin Yan, PhD, Senior Scientist, Department of Drug Metabolism and Pharmacokinetics, Genentech, Inc.

Donglu Zhang, PhD, Senior Scientist, Department of Drug Metabolism and Pharmacokinetics, Genentech, Inc.

Emerging Targets for Cancer Immunotherapy

Instructors:
Wayne W. Hancock, MD, PhD, Professor of Pathology and Chief of Transplant Immunology, Children's Hospital of Philadelphia and University of Pennsylvania Additional Instructors to be Announced

Monday April 8, 6:00 – 9:00 pm

Advancing Tools and Technologies for Fragment-Based Design

Instructors:
Daniel A. Erlanson, PhD, Co-Founder, Carmot Therapeutics, Inc.

Ben Davis, PhD, Research Fellow, Biology, Vernalis Research

Diversity-Oriented Platforms for Ligand Discovery

Instructors:
Sepideh Afshar, PhD, Principal Research Scientist, Department of Protein Engineering, Eli Lilly and Company

Svetlana Belyanskaya, PhD, Encoded Library Technologies, R&D Platform Technology & Science, GSK Boston

Targeted Protein Degradation Using PROTACS and Molecular Glues

Instructors:
Lara Gechijian, PhD, Scientist/Project Lead, Jnana Therapeutics; Former Graduate Student, Laboratory of Drs. James Bradner/Nathanael Gray, Harvard Medical School

Eric Fischer, PhD, Assistant Professor, Cancer Biology, Dana-Farber Cancer Institute/Harvard Medical School

Alexander Statsyuk, PhD, Assistant Professor, Department of Pharmacological and Pharmaceutical Sciences, University of Houston

Wednesday, April 10, 6:30 - 9:00 pm

Biochemistry and Pharmacology of the Ubiquitin-Proteasome System

Instructor:
Alexander Statsyuk, PhD, Assistant Professor, Department of Pharmacological and Pharmaceutical Sciences, University of Houston

Immunology Basics for Chemists

Instructor:
Songqing Na, PhD, Senior Scientist, Biotechnology & Autoimmunity Res-AME, Eli Lilly and Company

Macrocyclic Compounds for Drug Discovery: Opportunities, Challenges and Strategies

Instructors:
Eric Marsault, PhD, Professor, Medicinal Chemistry and Pharmacology, University of Sherbrooke

Mark Peterson, PhD, COO, Cyclenium Pharma, Inc.

GPCR Structure-Based Drug Discovery

Instructor:
Matthew Eddy, PhD, Assistant Professor, Chemistry, University of Florida

* 活动内容有可能不事先告知作更动及调整。